Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41 | 9 | 55 | 8 | 47 |
| Receivables | 9 | 17 | 6 | 11 | 7 |
| Inventories | 171 | 171 | 5 | 5 | 5 |
| TOTAL | $283 | $240 | $124 | $78 | $95 |
| Non-Current Assets | |||||
| PPE Net | 1 | 4 | 15 | 21 | 27 |
| Intangibles | 3,873 | 4,008 | 4,144 | 4,280 | 4,413 |
| TOTAL | $3,874 | $4,012 | $4,160 | $4,301 | $4,440 |
| Total Assets | $4,157 | $4,253 | $4,284 | $4,380 | $4,535 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 330 | 178 | 171 | 66 | 15 |
| Accounts payable and accrued liabilities | 266 | 213 | 21 | 17 | 15 |
| Accrued Expenses | 17 | 22 | 27 | 18 | 38 |
| Other current liabilities | 571 | 636 | 617 | 617 | 616 |
| TOTAL | $1,185 | $1,054 | $854 | $742 | $708 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $4 |
| Total Liabilities | $1,185 | $1,054 | $854 | $742 | $712 |
| Shareholders' Equity | |||||
| Common Shares | 9,701 | 9,701 | 9,701 | 9,701 | 9,701 |
| Retained earnings | -7,962 | -7,735 | -7,480 | -7,227 | -7,000 |
| Other shareholders' equity | 1,233 | 1,233 | 1,208 | 1,164 | 1,121 |
| TOTAL | $2,972 | $3,199 | $3,429 | $3,637 | $3,822 |
| Total Liabilities And Equity | $4,157 | $4,253 | $4,284 | $4,380 | $4,535 |